Pirisudanol
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
ATC code | N06BX08 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
Systematic (IUPAC) name: 2-(dimethylamino)ethyl[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridinyl]methylbutanedioate
|
|
CAS Number | 33605-94-6 ![]() |
PubChem (CID) | 65782 |
ChemSpider | 59202 |
UNII | W618Z2SMVL ![]() |
KEGG | D07347 ![]() |
Chemical and physical data | |
Formula | C16H24N2O6 |
Molar mass | 340.372 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Pirisudanol (Mentis, Menthen, Mentium, Nadex, Nadexen, Nadexon, Pridana, Stivane), also known as pyrisuccideanol, is the succinic acid ester of pyridoxine (a form of vitamin B6) and of deanol (DMAE).[1] It has been used in Europe in the treatment of mild cognitive impairment as well as fatigue and depression.[1][2][3][4][5]
See also[edit]
References[edit]
- ^ a b [+http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 "Psycho-Babble Medication Thread 69493"] Check
|url=
value (help). - ^ David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
- ^ Bathien N, Willer JC, Hugelin A (1976). "[Effect of psychotropic drugs on physiological variations and psychometric scores during attention]". L'Encéphale (in French). 2 (1): 55–60. PMID 1261486.
- ^ Murphy JE (1981). "An evaluation of pyrisuccideanol maleate (Nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice". The Journal of International Medical Research. 9 (5): 330–7. PMID 7297757.
- ^ Zmorski T (September 1983). "[Experience with Nadex in an ambulatory psychiatric practice]". Therapeutische Umschau. Revue Thérapeutique (in German). 40 (9): 817–20. PMID 6138876.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |